Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-4.2%
5Y CAGR-11.1%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-4.2%/yr
vs -5.2%/yr prior
5Y CAGR
-11.1%/yr
Recent acceleration
Acceleration
+1.0pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.75 | -38.4% |
| 2024 | 7.71 | +10.5% |
| 2023 | 6.97 | +29.2% |
| 2022 | 5.40 | -13.7% |
| 2021 | 6.26 | -26.7% |
| 2020 | 8.53 | +89.0% |
| 2019 | 4.51 | -32.5% |
| 2018 | 6.68 | -48.1% |
| 2017 | 12.88 | +30.5% |
| 2016 | 9.87 | - |